Exifone
CAS No. 52479-85-3
Exifone ( NSC 680919; NSC-680919; NSC680919 )
Catalog No. M27224 CAS No. 52479-85-3
Exifone is a mixed, nonessential activator of HDAC1 that is capable of binding to both free and substrate-bound enzyme, resulting in an increased relative maximal rate of HDAC1-catalyzed deacetylation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
|
25MG | 71 | In Stock |
|
50MG | 107 | In Stock |
|
100MG | 160 | In Stock |
|
200MG | 240 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameExifone
-
NoteResearch use only, not for human use.
-
Brief DescriptionExifone is a mixed, nonessential activator of HDAC1 that is capable of binding to both free and substrate-bound enzyme, resulting in an increased relative maximal rate of HDAC1-catalyzed deacetylation.
-
DescriptionExifone is a mixed, nonessential activator of HDAC1 that is capable of binding to both free and substrate-bound enzyme, resulting in an increased relative maximal rate of HDAC1-catalyzed deacetylation.
-
SynonymsNSC 680919; NSC-680919; NSC680919
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number52479-85-3
-
Formula Weight278.2
-
Molecular FormulaC13H10O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc1ccc(C(=O)c2cc(O)c(O)c(O)c2)c(O)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bednash JS, Weathington N, Londino J, et al. Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity. Nat Commun. 2017;8:15203.
molnova catalog
related products
-
Droxinostat
Droxinostat (NS-41080) is a selective HDAC inhibitor with IC50 of 16.9, 2.47 and 1.46 uM for HDAC3, HDAC6 and HDAC8, respectively.
-
WT-161
A potent, selective, and bioavailable HDAC6 inhibitor with IC50 0.4 nM.
-
ACY-775
ACY-775 (ACY775) is a potent and specific HDAC6 inhibitor (IC50=7.5 nM) with improved brain bioavailability.